Entering text into the input field will update the search result below

Zealand Pharma shares halted pending news

Sep. 06, 2018 4:06 PM ETZealand Pharma A/S (ZEAL) StockBy: Douglas W. House, SA News Editor
  • Nasdaq has suspended trading in Zealand Pharma (ZEAL) pending the release of news.
  • Update: The company has agreed to sell future royalty streams and $85M in potential milestones for Soliqua 100/33/Suliqua and Lyxumia/Adlyxin to Royalty Pharma for $205M. It will be debt-free after redeeming the outstanding royalty bond of $24.7M.
  • It will remain eligible to receive up to $15M from Sanofi, expected in 2020.
  • Management will host a conference call tomorrow, September 7, at 9:00 am ET to discuss the transaction.
  • Shares will resume trading at 4:35 pm ET.

Recommended For You

More Trending News

Related Stocks

SymbolLast Price% Chg
ZEAL--
Zealand Pharma A/S